|
|
Warner Chilcott News (NASDAQ:WCRX)
| Latest Warner Chilcott News Headlines | | Date | Time | Source | | | 11/10/2008 | 7:00AM | PRNUS | Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2008 and Updates 2008 Full Year Guidance
Growth of promoted products and reduced operating costs continue to drive solid earnings growth.
ST. DAVID'S, Bermuda, Nov. 10 /PRNewswire-FirstCall/ -- Warner Chilcott Limited (NASDAQ:WCRX) today announced its results for the quarter ended September 30, 2008. Revenue in the quarter ended September 30, 2008 totaled... More...>> |
| 10/14/2008 | 2:30PM | PRNUS | Warner Chilcott Announces Earnings Release Date and Conference Call for Third Quarter 2008 Financial Results
ST. DAVID'S, Bermuda, Oct. 14 /PRNewswire-FirstCall/ -- Warner Chilcott Limited (NASDAQ:WCRX) announced today that it will issue its third quarter 2008 financial results prior to the market opening on Monday, November 10, 2008.
In addition to issuing a press release, the Company will host a conference call for all... More...>> |
| 09/04/2008 | 4:14PM | PRNUS | Warner Chilcott to Present at the 2008 Morgan Stanley Global Healthcare Unplugged Conference
ST. DAVID'S, Bermuda, Sept. 4 /PRNewswire-FirstCall/ -- Warner Chilcott Limited (NASDAQ:WCRX) announced today that it will present at the 2008 Morgan Stanley Global Healthcare Unplugged Conference on Tuesday, September 9, 2008 at 10:20 a.m. EDT. Presenting for Warner Chilcott will be Roger Boissonneault, President... More...>> |
| 08/08/2008 | 7:00AM | PRNUS | Warner Chilcott Reports Operating Results for the Quarter Ended June 30, 2008 and Updates 2008 Full Year Guidance
Growth of promoted products and reduced operating costs continue to drive solid earnings growth.
ST. DAVID'S, Bermuda, Aug. 8 /PRNewswire-FirstCall/ -- Warner Chilcott Limited (NASDAQ:WCRX) today announced its results for the quarter ended June 30, 2008. Revenue in the quarter ended June 30, 2008 totaled $234.2 million... More...>> |
| 07/24/2008 | 4:15PM | PRNUS | Warner Chilcott Announces New Information in USPTO Reexamination of TACLONEX Patent
ST. DAVID'S, Bermuda, July 24 /PRNewswire-FirstCall/ -- Warner Chilcott Limited (NASDAQ:WCRX) announced today that LEO Pharma A/S ("LEO Pharma") has received a Right of Appeal Notice from the U.S. Patent and Trademark Office (the "USPTO"). In September 2006, the USPTO ordered a reexamination of LEO Pharma's US Patent... More...>> |
| 07/21/2008 | 2:43PM | PRNUS | Warner Chilcott Announces Earnings Release Date and Conference Call for Second Quarter 2008 Financial Results
ST. DAVID'S, Bermuda, July 21 /PRNewswire-FirstCall/ -- Warner Chilcott Limited (NASDAQ:WCRX) announced today that it will issue its second quarter 2008 financial results prior to the market opening on Friday, August 8, 2008.
In addition to issuing a press release, the Company will host a conference call for all interested... More...>> |
| 05/09/2008 | 7:00AM | PRNUS | Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance
Growth of promoted products and reduced operating costs drive solid earnings growth.
ST. DAVID'S, Bermuda, May 9 /PRNewswire-FirstCall/ -- Warner Chilcott Limited (NASDAQ:WCRX) today announced its results for the quarter ended March 31, 2008. Revenue in the quarter ended March 31, 2008 totaled $229.5 million, an increase... More...>> |
| 04/29/2008 | 5:30PM | PRNUS | Warner Chilcott Announces Settlement of Securities Litigation
ST. DAVID'S, Bermuda, April 29 /PRNewswire-FirstCall/ -- Warner Chilcott Limited (NASDAQ:WCRX) today announced that it has reached an agreement in principle to settle a securities class action lawsuit pending in the United States District Court for the Southern District of New York. The suit asserted claims under the... More...>> |
| 04/22/2008 | 4:30PM | PRNUS | Warner Chilcott Announces Earnings Release Date and Conference Call for First Quarter 2008 Financial Results
ST. DAVID'S, Bermuda, April 22 /PRNewswire-FirstCall/ -- Warner Chilcott Limited (NASDAQ:WCRX) announced today that it will issue its first quarter 2008 financial results prior to the market opening on Friday, May 9, 2008.
In addition to issuing a press release, the Company will host a conference call for all interested... More...>> |
| 03/14/2008 | 3:00PM | PRNUS | Warner Chilcott Reports the Death of Its Director James Andress
ST. DAVID'S, Bermuda, March 14 /PRNewswire-FirstCall/ -- It is with a profound sense of loss that Warner Chilcott Limited (NASDAQ:WCRX) reports today that Mr. James G. Andress, a director of the Company, died on Tuesday, March 11, 2008.
Roger Boissonneault, Chief Executive Officer, President and Director of Warner... More...>> |
| 02/29/2008 | 7:00AM | PRNUS | Warner Chilcott Reports Operating Results for the Quarter and Year ended December 31, 2007
Continued year over year growth driven by Loestrin 24 Fe and Taclonex
ST. DAVID'S, Bermuda, Feb. 29 /PRNewswire-FirstCall/ -- Warner Chilcott Limited (NASDAQ:WCRX) today announced its results for the quarter and year ended December 31, 2007. Revenue in the quarter ended December 31, 2007 totaled $227.7 million, an increase... More...>> |
| 02/13/2008 | 4:15PM | PRNUS | Warner Chilcott Announces Earnings Release Date and Conference Call for Fourth Quarter and Full Year 2007 Financial Results
ST. DAVID'S, Bermuda, Feb. 13 /PRNewswire-FirstCall/ -- Warner Chilcott Limited (NASDAQ:WCRX) announced today that it will issue its fourth quarter and full year 2007 financial results prior to the market opening on Friday, February 29, 2008.
In addition to issuing a press release, the Company will host a conference... More...>> |
| 01/28/2008 | 7:30AM | PRNUS | Warner Chilcott Announces 2008 Financial Guidance
ST. DAVID'S, Bermuda, Jan. 28 /PRNewswire-FirstCall/ -- Warner Chilcott Limited (NASDAQ:WCRX) announced today a view of anticipated full year 2008 results.
Total revenues for 2008 are expected to be in the range of $935 to $945 million, with the growth primarily being driven by LOESTRIN 24 FE, DORYX, FEMCON FE, and... More...>> |
| 01/24/2008 | 4:15PM | PRNUS | Warner Chilcott to Present at the 2008 Wachovia Healthcare Conference
ST. DAVID'S, Bermuda, Jan. 24 /PRNewswire-FirstCall/ -- Warner Chilcott Limited (NASDAQ:WCRX) announced today that it will present at the 2008 Wachovia Healthcare Conference on Wednesday, January 30, 2008 at 10:15 a.m. EST. Presenting for Warner Chilcott will be Paul Herendeen, Executive Vice President and Chief Financial... More...>> |
| 01/22/2008 | 8:00AM | PRNUS | Warner Chilcott Announces 2008 Financial Guidance Conference Call
ST. DAVID'S, Bermuda, Jan. 22 /PRNewswire-FirstCall/ -- Warner Chilcott Limited (NASDAQ:WCRX) announced today that it will issue its 2008 Financial Guidance prior to the market open on Monday, January 28, 2008. In addition to issuing a press release, Paul Herendeen, Executive Vice President and Chief Financial Officer... More...>> |
| 01/07/2008 | 11:00AM | PRNUS | Warner Chilcott to Present at the 26th Annual JPMorgan Healthcare Conference
ST. DAVID'S, Bermuda, Jan. 7 /PRNewswire-FirstCall/ -- Warner Chilcott Limited (NASDAQ:WCRX) announced today that it will present at the 26th Annual JPMorgan Healthcare Conference on Wednesday, January 9, 2008 at 3:00 p.m. Pacific Standard Time. Presenting for Warner Chilcott will be Paul Herendeen, Executive Vice... More...>> |
| 01/02/2008 | 3:05PM | PRNUS | Warner Chilcott to Present at the 2008 Morgan Stanley Pharmaceutical CEO's Unplugged Conference
ST. DAVID'S, Bermuda, Jan. 2 /PRNewswire-FirstCall/ -- Warner Chilcott Limited (NASDAQ:WCRX) announced today that it will present at the Morgan Stanley Pharmaceutical CEO's Unplugged Conference on Friday, January 4, 2008 at 2:30 p.m. EST. Presenting for Warner Chilcott will be Roger Boissonneault, President and Chief... More...>> |
| 11/09/2007 | 7:00AM | PRNUS | Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007
Continued year over year growth driven by Loestrin 24 and Taclonex; Company updates full year 2007 financial guidance
ST. DAVID'S, Bermuda, Nov. 9 /PRNewswire-FirstCall/ -- Warner Chilcott Limited (NASDAQ:WCRX) today announced its results for the quarter ended September 30, 2007. Revenue in the quarter ended September... More...>> |
| 11/08/2007 | 5:00PM | PRNUS | Warner Chilcott Announces Settlement of Remaining Class Action Suit Brought by Direct Purchasers
ST. DAVID'S, Bermuda, Nov. 8 /PRNewswire-FirstCall/ -- Warner Chilcott Limited (NASDAQ:WCRX) announced today that it has reached a tentative settlement to conclude the one remaining antitrust lawsuit involving one of the Company's combined hormonal contraceptives, Ovcon 35. Under the proposed settlement, all claims... More...>> |
| 10/29/2007 | 8:00AM | PRNUS | Warner Chilcott and Watson Pharmaceuticals Announce Launch of Tilia(TM) Fe
FAJARDO, Puerto Rico and CORONA, Calif., Oct. 29 /PRNewswire-FirstCall/ -- Warner Chilcott Company, Inc. and Watson Pharmaceuticals, Inc. announced today that under a supply agreement between Warner Chilcott and Watson Pharma, Inc., Watson has launched Tilia(TM) Fe (norethindrone acetate and ethinyl estradiol tablets... More...>> |
|
|
|